Back
Fidelity National Information Services Vs. Mirum Pharmaceuticals Industry Stock Comparison
Buy
51
FIS
Fidelity National Information Services
Last Price:
75.32
Seasonality Move:
-2.02%
Buy
77
MIRM
Mirum Pharmaceuticals
Last Price:
34.15
Seasonality Move:
6.63%
Buy
51
Fidelity National Information Services (FIS)
is a Buy
Is Fidelity National Information Services a Buy, Sell or Hold?
- The current Fidelity National Information Services [FIS] share price is $75.36. The Score for FIS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- FIS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
77
Mirum Pharmaceuticals (MIRM)
is a Buy
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
- The current Mirum Pharmaceuticals [MIRM] share price is $34.19. The Score for MIRM is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- MIRM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FIS Stock Price Chart
What is Fidelity National Information Services's stock price today?
-
The Fidelity National Information Services share price today is $75.36
The current trend is relatively stagnant and FIS is experiencing buying pressure, which is a positive indicator for future bullish movement.
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $34.19
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIRM is experiencing buying pressure, which is a positive indicator for future bullish movement.
FIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 48.46 | Sell |
| Chaikin Money Flow: | 3640788 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (75.09 - 76.97) | Sell |
| Bollinger Bands (100): | (66.99 - 76.11) | Buy |
MIRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.24 | Buy |
| Relative Strength Index (14 RSI): | 66.2 | Buy |
| Chaikin Money Flow: | 1534746 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.34 - 31.66) | Buy |
| Bollinger Bands (100): | (24.32 - 29.22) | Buy |
FIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 75.65 | Sell |
| 20-day SMA: | 76.14 | Sell |
| 50-day SMA: | 74.52 | Buy |
| 200-day SMA: | 64.13 | Buy |
| 8-day EMA: | 75.49 | Sell |
| 20-day EMA: | 75.76 | Sell |
| 50-day EMA: | 74.53 | Buy |
| 200-day EMA: | 67.82 | Buy |
MIRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.57 | Buy |
| 20-day SMA: | 28.83 | Buy |
| 50-day SMA: | 26.5 | Buy |
| 200-day SMA: | 28.22 | Buy |
| 8-day EMA: | 32.4 | Buy |
| 20-day EMA: | 29.9 | Buy |
| 50-day EMA: | 27.73 | Buy |
| 200-day EMA: | 27.19 | Buy |
Fidelity National Information Services Earnings Growth & FIS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.08 per share, an increase this year of $1.62 per share, and an increase next year of $0.54 per share.
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.34 per share, an increase this year of $1.92 per share, and an increase next year of $1.37 per share.
Fidelity National Information Services Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Mirum Pharmaceuticals Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||